Our History

In the fast-growing metroplex of Phoenix, Arizona, we formed Calviri in 2017 to end cancer. We were convinced this could be done because we had discovered a previously unappreciated, yet fundamental, molecular characteristic of all tumors that distinguishes them from healthy host cells.  We had also invented chip technologies that would let us leverage our discovery to uniquely battle cancer.

After years of research and many patents, we are now developing multi-cancer tests to accurately detect stage 1 disease, which can be treated with our early-stage therapeutic vaccines. Our research has also shown us the path to the seeming impossible: a preventative cancer vaccine. All rooted in the power of our molecular discoveries and semiconductor inventions, we are now ready to globally provide diagnostics and vaccines that will end cancer.

Full stop.